Feedback / Questions
iloprost intravenous (CIVI030) - CiVi Biopharma
https://www.prnewswire.com/news-releases/civi-biopharma-resumes-aurora-phase-3-clinical-trial-of-civi030-to-treat-systemic-sclerosis-301143657.html
Oct 1, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next